The effect of age specific FSH levels on in vitro fertilization-intracytoplasmic sperm injection/embryo transfer outcomes in women with normal ovarian function

Basit Öğe Kaydı
dc.authorscopusid57189659110
dc.authorscopusid55193447200
dc.authorscopusid6508056191
dc.contributor.authorYar T.
dc.contributor.authorMeleko?lu R.
dc.contributor.authorÜrünsak I.F.
dc.date.accessioned2024-08-04T20:00:54Z
dc.date.available2024-08-04T20:00:54Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: The objective of this study is to determine the effect of age specific follicle stimulating hormone (FSH) levels on the number of oocytes, the number of MII oocytes, fertilization, the number of grade 1 embryos and pregnancy rate in vomen with normal ovarian function for in vitro fertilization-intracytoplasmic sperm injection/embryo transfer cycles. Material and Methods: In this study 392 patients data were reviewed retrospectively between 01.01.2010-01.01.2014 at Çukurova University Faculty of Medicine Department of Obstetrics and Gynecology Assisted Reproduction Treatment Centre who used recombinant follicle stimulating hormone for controlled ovarian stimulation than performed in vitro fertilization-intracytoplasmic sperm injection/embryo transfer due to unexplained infertility. Patients were grouped as women of age 33 and lower, 33-37 and 38-41. Each age group were divided into two subgroups; premature ovaraian aging and control group. Subgroups in all age groups were compared in terms of baseline characteristics and in vitro fertilization (IVF) results. Results: In younger age group the total gonadotropin dose used and the duration of induction were detected statistically significantly higher than premature ovarian aging (POA) patients in control patients. (p=0.004, p=0.048) E2 level at hCG administration day, number of oocytes obtained and the number of MII oocytes were lower than the control group in POA patients (p=0,001, p=0.022, p=0.023 respectively). In the 33-37 age range, in the POA group E2 level at hCG administration day, number of oocytes and the number of MII oocytes retrieved was lower than the control group (p<0.0001, p=0.027, p=0.040 respectively). Conclusion: Interperation and consideration of age-specific FSH levels in treatment planning while taking into account the patient's age may contribute to optimize the IVF outcomes in patients undergoing controlled ovarian hyperstimulation. © Copyright 2016 by Türkiye Klinikleri.en_US
dc.identifier.doi10.5336/gynobstet.2015-48053
dc.identifier.endpage37en_US
dc.identifier.issn1300-0306
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84973917478en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage31en_US
dc.identifier.urihttps://doi.org/10.5336/gynobstet.2015-48053
dc.identifier.urihttps://hdl.handle.net/11616/91109
dc.identifier.volume26en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherOrtadogŸu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret A.S.en_US
dc.relation.ispartofTurkiye Klinikleri Jinekoloji Obstetriken_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAge groupsen_US
dc.subjectEmbryo transferen_US
dc.subjectFertilization in vitroen_US
dc.subjectFollicle stimulating hormoneen_US
dc.subjectSperm injection, intracytoplasmicen_US
dc.titleThe effect of age specific FSH levels on in vitro fertilization-intracytoplasmic sperm injection/embryo transfer outcomes in women with normal ovarian functionen_US
dc.title.alternativeNormal Ovaryan Fonksiyonu Olan Kadinlarda Yaşspesifikfshseviyelerinin In Vitro Fertilizasyon-Intrasitoplazmik Sperm Enjeksiyonu/Embriyo Transferi Sonuçlari Üzerine Etkisien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu